angiotensin II (Human) [866]
angiotensin II (Human)
| SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O |
| InChIKey | CZGUSIXMZVURDU-JZXHSEFVSA-N |
| Sequence | DRVYIHPF |
| HELM | PEPTIDE1{D.R.V.Y.I.H.P.F}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 13 |
| Hydrogen bond donors | 13 |
| Rotatable bonds | 29 |
| Log P | -1.315 |
| Molecular weight (Da) | 1045.5 |
| Stereochemistry info | partial |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
angiotensin II (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
2
Phase II
0
Phase III
0
Phase IV
2
Sankey plot
Drug Information
| Target | Disease | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gene | Protein | Receptor family | Ligand type | Class | Name | Phase | ICD11 | ATC | Association score |